This stock is so easy to read now - it won’t go anywhere till the actual revenue is booked. The company has cried ‘wolf’ so many times that investors would like to see actual proof of revenues rather than singing the praises of technology. The Zeiss Convivo also has not yielded much revenue. The Invivage still stuck in regulatory limbo due to no suitable contrast agent approved by FDA. Even company’s own financial summary states no net profit till 5 years from now - plenty of time till then!
Good signs ...., page-330
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $154.5M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 18.0¢ | $63.04K | 340.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 109961 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| OIL (ASX) Chart |